Literature DB >> 4616827

Current status of immunotherapy of human cancers: leukaemias, lymphomas, solid tumours.

G Mathé.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4616827     DOI： 10.2165/00003495-197408060-00004

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  21 in total

1.  SUCCESSFUL ALLOGENIC BONE MARROW TRANSPLANTATION IN MAN: CHIMERISM, INDUCED SPECIFIC TOLERANCE AND POSSIBLE ANTI-LEUKEMIC EFFECTS.

Authors:  G MATHE; J L AMIEL; L SCHWARZENBERG; A CATTAN; M SCHNEIDER; M J DEVRIES; M TUBIANA; C LALANNE; J L BINET; M PAPIERNIK; G SEMAN; M MATSUKURA; A M MERY; V SCHWARZMANN; A FLAISLER
Journal:  Blood       Date:  1965-02       Impact factor: 22.113

2.  [Transfusions and grafts of homologous bone marrow in humans after accidental high dosage irradiation].

Authors:  G MATHE; H JAMMET; B PENDIC; L SCHWARZENBERG; J F DUPLAN; B MAUPIN; R LATARJET; M J LARRIEU; D KALIC; Z DJUKIC
Journal:  Rev Fr Etud Clin Biol       Date:  1959-03

Review 3.  Active immunotherapy.

Authors:  G Mathé
Journal:  Adv Cancer Res       Date:  1971       Impact factor: 6.242

4.  Preliminary results of nonspecific immunotherapy for lung cancer.

Authors:  L Israel
Journal:  Cancer Chemother Rep 3       Date:  1973-03

5.  Immunological effects of BCG in malignant melanoma: two modes of administration compared.

Authors:  A Z Bluming; C L Vogel; J L Ziegler; N Mody; G Kamya
Journal:  Ann Intern Med       Date:  1972-03       Impact factor: 25.391

Review 6.  Recent trends in tumor immunology.

Authors:  G Klein
Journal:  Isr J Med Sci       Date:  1966 Mar-Apr

7.  [Active immunotherapy of acute leukemia and leukemic lymphosarcoma. Results of 10 years. Study of 200 cases].

Authors:  G Mathé; J L Amiel; L Schwarzenberg; M Hayat; P Pouillart; M Schneider; A Cattan; C Jasmin; D Belpomme; J R Schlumberger; F De Vassal; M Musset; J L Misset
Journal:  Nouv Presse Med       Date:  1975-05-03

8.  Progress in the prevention of GVH: bone marrow grafts after ALG conditioning, with lymphocyte split chimerism, use of a lymphocyte "chalone T", and soluble histocompatibility antigens.

Authors:  G Mathé; N Kiger; I Florentin; E Garcia-Giralt; M C Martyre; O Halle-Pannenko; L Schwartzenberg
Journal:  Transplant Proc       Date:  1973-03       Impact factor: 1.066

9.  Marrow grafting in patients with acute leukemia.

Authors:  E D Thomas; C D Buckner; R A Clift; L Fass; A Fefer; K G Lerner; P Neiman; N Rowley; R Storb
Journal:  Transplant Proc       Date:  1973-03       Impact factor: 1.066

10.  Active immunotherapy of L1210 leukaemia applied after the graft of tumour cells.

Authors:  G Mathé; P Pouillart; F Lapeyraque
Journal:  Br J Cancer       Date:  1969-12       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.